Wolf Theiss has advised Japan's Takeda Group on its April 3, 2019 acquisition of plasma donation center Plasmapunk Favoriten and Donaustadt.
Wolf Theiss describes Takeda as "a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing better health to people worldwide. The passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan."
The Wolf Theiss team was led by Partner Sarah Wared and included Partners Niklas Schmidt, Roland Marko, Kurt Retter and Karl Binder, Counsels Eva Stadler and Walter Poschl, Senior Associates Paulina Pomorski, Georg Harer, and Associates Clemens Pretscher, Michael Kienzl, Simona Shpilsky, Vilma-Reeta Kivilahti, Dominik Engel, Valentina Riedler, and Iris Riepan.
Wolf Theiss did not reply to our inquiry on this matter.